Trends in Stroke Prevention between 2014 and 2018 in Hospitalized Atrial Fibrillation Patients

Table 3

Factors increasing the chances of using non-vitamin K antagonist oral anticoagulant in analysed patients—multivariate logistic regression analysis.

Factors	OR	95% CI
Age (per year)	1.02	1.01–1.03	<0.001
Heart failure	0.84	0.70–1.00	0.057
Diabetes mellitus	0.88	0.74–1.05	0.163
Previous thromboembolism event	1.29	1.01–1.65	0.038
Vascular disease	0.91	0.77–1.09	0.320
Nonpermanent AF	1.61	1.34–1.93	<0.001
eGFR (per unit)	1.22	1.02–1.46	0.030
LA diameter	0.97	0.96–0.98	<0.001
Antiplatelet drug/drugs	0.68	0.51–0.92	0.011

AF: atrial fibrillation; CI: confidence interval; eGFR: estimated glomerular filtration rate; LA: left atrium; and OR: odds ratio.